CBR3
protein-codingcarbonyl reductase 3, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CBR3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001236.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 49 | 1 | 1 | 51 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 51 | 1 | 1 | 53 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001227.1 | 3 | MANE Select | |
| Ensembl | ENSP00000290354.5 | 3 | MANE Select | |
| Ensembl | ENSP00000596214.1 | 2 | Standard | |
| Ensembl | ENSP00000596214.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Doxorubicin Pathway (Cardiomyocyte Cell), Pharmacodynamics
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)
- Arachidonic acid metabolism - Homo sapiens (human)
- Doxorubicin Pathway, Pharmacokinetics
- Doxorubicin Metabolism Pathway
Biological Process
- xenobiotic metabolic process
- phylloquinone catabolic process
- cognition
- oxidation-reduction process
Molecular Function
- 3-keto sterol reductase activity
- carbonyl reductase (NADPH) activity
- protein binding
- NADPH binding
Cellular Component
- extracellular space
- nucleoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000290354
- Coding exons
- 3
- Length
- 11655
- Individuals with no LoFs
- 125384
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 362
- Defined
- 125748
- p
- 0.00145
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0345 | 155 | 154 | 1.01 | 0.00000722 | 1811 |
| Missense (PolyPhen) | 38 | 36.974 | 1.0277 | 453 | ||
| Synonymous | 0.940 | 56 | 65.7 | 0.852 | 0.00000326 | 549 |
| Loss of Function | -0.256 | 8 | 7.26 | 1.10 | 3.08e-7 | 95 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.0015 | 0.0014 | notable |
| Ashkenazi Jewish | 0.023 | 0.023 | notable |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00049 | 0.00049 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Has low NADPH-dependent oxidoreductase activity towards 4-benzoylpyridine and menadione (in vitro). {ECO:0000269|PubMed:18493841}.;
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- LoFtool
- 0.601
- RVIS EVS
- 0.46
- RVIS percentile EVS
- 78.46
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.726
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |